1.74
Schlusskurs vom Vortag:
$1.74
Offen:
$1.74
24-Stunden-Volumen:
304.19K
Relative Volume:
0.50
Marktkapitalisierung:
$70.90M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-1.0875
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
+1.75%
1M Leistung:
+6.10%
6M Leistung:
-78.75%
1J Leistung:
-74.93%
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LUNG
Pulmonx Corp
|
1.74 | 70.90M | 68.68M | -60.84M | -38.42M | -1.60 |
![]()
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-31 | Herabstufung | Piper Sandler | Overweight → Neutral |
2025-03-10 | Eingeleitet | D. Boral Capital | Buy |
2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
2024-06-04 | Eingeleitet | Lake Street | Buy |
2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2023-09-05 | Eingeleitet | Craig Hallum | Buy |
2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
2021-04-01 | Eingeleitet | Citigroup | Buy |
2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
2020-10-26 | Eingeleitet | BofA Securities | Buy |
2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
2020-10-26 | Eingeleitet | Stifel | Buy |
2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Is Pulmonx Corporation stock poised for growthJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Real time pattern detection on Pulmonx Corporation stock2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Chart based analysis of Pulmonx Corporation trends2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Pulmonx Corporation Reaches Critical Trendline SupportWeekly Risk Summary & Safe Swing Trade Setup Alerts - beatles.ru
Pulmonx at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com
Will Pulmonx Corporation stock recover after recent dropJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Using R and stats models for Pulmonx Corporation forecastingJuly 2025 Highlights & Free Real-Time Market Sentiment Alerts - Newser
Pattern recognition hints at Pulmonx Corporation upsideSell Signal & High Return Stock Watch Alerts - Newser
Will Pulmonx Corporation bounce back from current supportJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
Pulmonx Corp Executives Sell Shares to Cover Tax Obligations - TradingView
Will breakout in Pulmonx Corporation lead to full recoveryJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Backtesting results for Pulmonx Corporation trading strategiesMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
How to build a custom watchlist for Pulmonx CorporationWeekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Using data tools to time your Pulmonx Corporation exitJuly 2025 Institutional & Verified Short-Term Plans - Newser
How to track smart money flows in Pulmonx Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
What data driven models say about Pulmonx Corporation’s future2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
What Fibonacci levels say about Pulmonx Corporation reboundJuly 2025 Retail & Growth Focused Stock Reports - Newser
What are the future prospects of Pulmonx CorporationMarket Volume Report & Long-Term Safe Investment Plans - khodrobank.com
Can trapped investors hope for a rebound in Pulmonx Corporation2025 Price Momentum & Consistent Growth Stock Picks - Newser
Does Pulmonx Corporation fit your quant trading model2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Pulmonx CorporationCPI Data & Weekly Return Optimization Plans - Newser
Is Pulmonx Corporation meeting your algorithmic filter criteriaTrade Performance Summary & AI Optimized Trade Strategies - Newser
Trend analysis for Pulmonx Corporation this weekQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Pulmonx CorporationVolume Spike & Daily Volume Surge Signals - Newser
How to escape a deep drawdown in Pulmonx Corporation2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Real time alert setup for Pulmonx Corporation performanceTrade Ideas & Stepwise Trade Signal Implementation - Newser
Pulmonx (NASDAQ:LUNG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Applying big data sentiment scoring on Pulmonx CorporationJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Published on: 2025-08-29 19:26:58 - Newser
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):